FDA Approved: CARVEDILOL — Supplemental Application (Aurobindo Pharma Limited)

View source ↗

Summary

FDA approved a supplemental application for carvedilol from Aurobindo Pharma Limited, confirming a generic version under ANDA078332.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Heart Failure
• Hypertension
• Postmyocardial Infarction

Drugs mentioned

• CARVEDILOL (Carvedilol)

Snippet

SUPPL AP for CARVEDILOL (CARVEDILOL)